Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2025
Validation of a Digital Pathology-Based Multimodal Artificial Intelligence Biomarker in a Prospective, Real-World Prostate Cancer Cohort Treated with ProstatectomyAnders Bjartell, Agnieszka Krzyzanowska, Vinnie Y T Liu, et al.Cancer Medicine|November 18, 2022
Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate-risk clear cell kidney cancerNeal Patel, Alexander Hakansson, Shinji Ohtake, et al.BJUI Compass|April 27, 2022
Impact of Decipher on use of post-operative radiotherapy: Individual patient analysis of two prospective registriesMohammed Shahait, Vinnie Y T Liu, Neha Vapiwala, et al.The Journal of Urology|October 13, 2021
Patients with Muscle-Invasive Bladder Cancer with Nonluminal Subtype Derive Greatest Benefit from Platinum Based Neoadjuvant ChemotherapyYair Lotan, Joep J de Jong, Vinnie Y T Liu, et al.International Journal of Radiation Oncology, Biology, Physics|May 3, 2023
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 TrialDaniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III TrialsAndrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.The Lancet. Digital Health|June 4, 2025
External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE platform protocolCharles T A Parker, Larissa Mendes, Vinnie Y T Liu, et al.Pageof 1